Four new U.S. transactions were announced or confirmed in the July 22–23, 2026 period, spanning life sciences software, Permian Basin oil and gas, quantum computing, and critical minerals. Two significant process updates — the McCormick–Unilever Foods integration planning disclosure and the EU clearance of the Electronic Arts acquisition — are also covered below.

Parties: Dassault Systèmes (France); ArisGlobal (United States)
Sector: Life sciences software, artificial intelligence, and regulatory compliance
Transaction value: Approximately $1.8 billion cash at closing, plus up to $200 million in contingent consideration tied to AI revenue targets
Expected closing: Second half of 2026, subject to regulatory approvals

Dassault Systèmes has agreed to acquire ArisGlobal, a U.S.-based provider of AI-powered software for pharmacovigilance, regulatory submissions, quality management, and medical affairs. ArisGlobal's platform serves more than 200 customers and processes more than 12 million patient safety reports annually. The transaction is expected to close in the second half of 2026 following regulatory approvals.

Commercial significance. The acquisition allows Dassault to combine its clinical trial and manufacturing software with real-world data and regulatory compliance workflows — creating an integrated life sciences platform from development through post-market surveillance. The contingent consideration structure — up to $200 million tied to future AI-related revenues — allocates technology valuation uncertainty between buyer and seller, with the seller retaining upside if the AI platform outperforms projections.

Practice notes. The earnout mechanics require careful drafting: which products and revenue streams count as "AI-related revenue"; how revenues are allocated post-integration when ArisGlobal's platform is bundled with Dassault's existing products; and what obligations the buyer has to develop and promote the AI platform during the earnout period. Patient safety data, cross-border health data transfers, relationships with the FDA and other health regulators, and cybersecurity obligations are core due diligence areas. The regulatory approval process may involve review by competition authorities in the EU and potentially the United States.

Parties: Matador Resources; Paloma Permian; seller: EnCap Investments
Sector: Oil and gas (upstream)
Transaction value: Approximately $1.28 billion
Expected closing: Fourth quarter of 2026

Matador Resources has agreed to acquire Paloma Permian's assets in Eddy and Lea counties, New Mexico — approximately 16,235 net undeveloped acres and approximately 11,100 barrels of oil equivalent per day of current production. The portfolio is reported to include 55 million barrels of oil equivalent in proved reserves and more than 156 net drilling locations.

Commercial significance. U.S. shale consolidation has shifted toward acquiring existing, high-quality reserves rather than accelerating production through new drilling. The transaction extends Matador's reserve life and future drilling inventory in the Delaware Basin, a core operating area. The seller, EnCap Investments, is a private equity firm — the transaction represents a PE exit at a time when upstream asset valuations remain supported by commodity prices.

Practice notes. Due diligence should cover: the chain of title for mineral and leasehold rights; well plugging and abandonment liabilities; environmental obligations (including produced water disposal); joint operating agreements; midstream capacity commitments; and commodity price hedging positions. If the transaction is structured as an asset acquisition rather than a stock purchase, specific indemnification and escrow mechanisms should be negotiated to leave historical environmental liabilities with the seller.

Parties: IBM; Boeing; General Motors; HRL Laboratories
Sector: Quantum computing, semiconductors, and advanced technology
Transaction value: Not disclosed
Status: Acquisition agreement announced

IBM has agreed to acquire HRL Laboratories, which is jointly owned by Boeing and General Motors. HRL's electron-spin-based quantum circuits will add a second technology track to IBM's quantum program, which is primarily based on superconducting circuits. HRL's chip manufacturing is planned to be relocated to IBM's facilities in New York; Boeing and GM will continue to work with IBM on quantum technologies.

Commercial significance. The transaction is a strategic technology acquisition focused on intellectual property and specialized talent. The continued collaboration by Boeing and GM after the sale suggests that long-term research, licensing, or development agreements have been entered into alongside the acquisition — a structure that preserves the sellers' access to HRL's technology while monetizing the asset.

Practice notes. Patent ownership, rights arising from government-funded research (including Bayh-Dole Act considerations), export controls, security clearances, and change-of-control provisions in government contracts will be critical. The defense and dual-use technology character of HRL's work means that ITAR, EAR, and federal security regulations will require careful analysis. The planned relocation of chip manufacturing to New York may also trigger state and local incentive agreement review.

Parties: Nth Cycle Inc.; Kensington Capital Acquisition Corp. VI
Sector: Critical minerals, battery metals, and recycling technology
Pro forma enterprise value: Approximately $585 million
Expected closing: Fourth quarter of 2026

Nth Cycle plans to become a publicly traded company listed on the NYSE under the ticker "NTH" through a SPAC business combination with Kensington Capital Acquisition Corp. VI. The transaction is expected to provide up to $230 million from Kensington's trust account (subject to investor redemptions) and up to $100 million from a PIPE investment, of which $40 million was committed as of the announcement date.

Commercial significance. Nth Cycle's technology for processing rare earth elements, copper, and battery metals is directly aligned with U.S. policy to onshore critical mineral processing capacity. The company's ability to process battery recycling streams and primary ore positions it at the intersection of the EV supply chain and domestic critical minerals policy. However, the SPAC structure's redemption right means that the net cash reaching the company could be significantly lower than the headline trust amount.

Practice notes. The merger agreement should be reviewed for: minimum cash conditions; investor redemption rates and their effect on closing certainty; the firmness of PIPE commitments; and transaction expenses. The SEC registration statement will require comprehensive disclosure on revenue projections, commercial scale-up, government incentives (including IRA and CHIPS Act eligibility), environmental permits, and long-term offtake agreements. Turkish companies in the battery materials or EV supply chain space should monitor this transaction as a reference point for U.S. critical minerals processing valuations.

McCormick disclosed that the combined company plans a secondary listing on the London Stock Exchange in addition to its primary NYSE listing, and that the organization will be structured around four divisions: Americas Consumer, International Consumer, Global Food Service, and Global Flavor. The transaction is expected to close in mid-2027.

Practice note. The disclosure indicates that the parties have advanced pre-closing integration planning to a significant degree. However, management teams should not implement coordinated commercial decisions before closing due to gun-jumping risk under U.S. and EU competition law. The London secondary listing will require separate preparation for dual-market disclosure obligations, corporate governance, and investor relations.

The European Commission granted unconditional merger control clearance for the acquisition of Electronic Arts by the consortium of Saudi Arabia's Public Investment Fund, Silver Lake, and Affinity Partners. A separate review under the EU Foreign Subsidies Regulation is ongoing, with a decision date of July 30, 2026.

Life sciences and pharma. Turkish pharmaceutical and medical device companies with U.S. regulatory submissions or pharmacovigilance programs should monitor the Dassault–ArisGlobal integration, as ArisGlobal's platform is widely used in the industry. Post-acquisition pricing and platform changes may affect existing customer relationships.

Energy. Turkish energy companies with U.S. upstream interests or considering U.S. oil and gas acquisitions should note the Matador–Paloma transaction as a reference for Delaware Basin asset valuations and deal structure in PE-exit transactions.

Critical minerals. Turkish companies in the battery materials, mining, or EV supply chain sectors should monitor the Nth Cycle SPAC as a reference for U.S. critical minerals processing valuations and the regulatory and commercial milestones that U.S. investors are applying to this sector.

Technology M&A. The IBM–HRL transaction illustrates the complexity of acquiring U.S. defense-adjacent technology assets — export controls, security clearances, and government contract change-of-control provisions are non-negotiable diligence items for any Turkish company considering a U.S. technology acquisition.

ULF New York advises Turkish companies and investors on U.S. M&A, CFIUS review, cross-border transaction structuring, and regulatory compliance in U.S. acquisitions.